等待开盘 01-30 09:30:00 美东时间
-0.110
-9.57%
Enlivex ( ($ENLV) ) has provided an update. On January 26, 2026, Enlivex announ...
01-26 21:27
Enlivex Therapeutics Ltd. announced the listing of its primary treasury asset, the RAIN token, on the WhiteBIT cryptocurrency exchange, enhancing market access and liquidity for RAIN. RAIN is a governance and utility token for a decentralized predictions and options protocol on the Arbitrum network. Enlivex focuses on late-stage clinical development of Allocetra™ for treating osteoarthritis, impacting millions globally with limited treatment opti...
01-26 13:00
Enlivex Therapeutics Ltd. announced its plan to voluntarily delist its ordinary shares from the Tel Aviv Stock Exchange (TASE) to streamline operations, reduce administrative costs, and enhance liquidity on Nasdaq. The last day of trading on TASE is expected to be April 23, 2026, with delisting on April 26, 2026. The shares will remain listed on Nasdaq under the symbol "ENLV," and the company will continue filing SEC reports. The move aims to foc...
01-23 13:00
Enlivex's RAIN token begins trading on KuCoin as analysts raise price targets, citing growing prediction markets and token burn mechanics.
01-15 00:46
今日重点评级关注:HC Wainwright & Co.:维持Enlivex Therapeutics"买入"评级,目标价从7美元升至13美元;BTIG:维持Oruka Therapeutics"买入"评级,目标价从63美元升至73美元
01-13 10:18
Enlivex Therapeutics Ltd. announced the listing of its RAIN token on KuCoin, a major global cryptocurrency exchange with over 40 million users, enhancing market access and liquidity for its digital treasury asset. KuCoin, founded in 2017, ranks among the top ten exchanges globally, offering deep liquidity and various trading products. The move is expected to support Enlivex's treasury strategy and expand RAIN's global presence. RAIN serves as the...
01-07 13:00
Enlivex Therapeutics will host a virtual fireside chat on December 11, 2025, at 11:00 am ET. Shai Novik, the company's Executive Chairman, will discuss updates following the recent $212 million private placement, including the launch of a digital asset treasury strategy focused on RAIN token accumulation and the advancement of Allocetra's clinical development for treating osteoarthritis. The event will include a Q&A session, and a recording will ...
2025-12-04 13:00
Enlivex ( ($ENLV) ) just unveiled an announcement. On November 24, 2025, Enlive...
2025-11-26 21:28
Antelope Enterprise Holdings, Enlivex Therapeutics, and Inno Holdings are the 3...
2025-11-25 23:13
D. Boral Capital analyst Jason Kolbert downgrades Enlivex Therapeutics (NASDAQ:ENLV) from Buy to Hold.
2025-11-24 23:41